Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New oxygen sensor tested on skin cancers

NCT ID NCT03716193

First seen Mar 05, 2026 · Last updated Jun 20, 2026 · Updated 11 times

Summary

This study tested a method called EPR oximetry to measure oxygen levels in skin tumors. Researchers gave patients pure oxygen through a face mask and tracked how tumor oxygen changed. Only 3 people took part before the study was stopped, so the findings are very limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Todd Tenenholz

    Morgantown, West Virginia, 26506, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

oxygen

What this could lead to

If successful, this could help doctors better understand how oxygen levels in skin tumors change during treatment, potentially guiding more effective cancer therapies.

What could go wrong

This was a very small, early feasibility study with only 3 participants and was terminated early, so results may not be reliable or generalizable.

Conditions

The condition(s) this trial relates to.

melanoma skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.